These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21701160)

  • 1. Hemochromatosis, HFE C282Y homozygosity, and polycystic ovary syndrome: report of two cases and possible effects of androgens and hepcidin.
    Barton JC; Barton JC
    Acta Haematol; 2011; 126(3):138-40. PubMed ID: 21701160
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter by Sullivan regarding article, "HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: the hemochromatosis and iron overload screening study".
    Sullivan JL
    Circ Cardiovasc Genet; 2009 Jun; 2(3):e1. PubMed ID: 20031587
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of new mutations of hepcidin and hemojuvelin in patients with HFE C282Y allele.
    Biasiotto G; Roetto A; Daraio F; Polotti A; Gerardi GM; Girelli D; Cremonesi L; Arosio P; Camaschella C
    Blood Cells Mol Dis; 2004; 33(3):338-43. PubMed ID: 15528154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum hepcidin levels are innately low in HFE-related haemochromatosis but differ between C282Y-homozygotes with elevated and normal ferritin levels.
    van Dijk BA; Laarakkers CM; Klaver SM; Jacobs EM; van Tits LJ; Janssen MC; Swinkels DW
    Br J Haematol; 2008 Sep; 142(6):979-85. PubMed ID: 18557745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blunted increase in serum hepcidin as response to oral iron in HFE-hemochromatosis.
    Sangwaiya A; Manglam V; Busbridge M; Thursz M; Arnold J
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):721-4. PubMed ID: 21654321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
    Barton JC; Acton RT; Leiendecker-Foster C; Lovato L; Adams PC; McLaren GD; Eckfeldt JH; McLaren CE; Reboussin DM; Gordeuk VR; Speechley MR; Reiss JA; Press RD; Dawkins FW;
    Genet Test; 2007; 11(3):269-75. PubMed ID: 17949288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased iron burden in overweight C282Y homozygous women: Putative role of increased hepcidin production.
    Desgrippes R; Lainé F; Morcet J; Perrin M; Manet G; Jezequel C; Bardou-Jacquet E; Ropert M; Deugnier Y
    Hepatology; 2013 May; 57(5):1784-92. PubMed ID: 23322654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemochromatosis: genetics and pathophysiology.
    Beutler E
    Annu Rev Med; 2006; 57():331-47. PubMed ID: 16409153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective role of calreticulin in HFE hemochromatosis.
    Pinto JP; Ramos P; de Almeida SF; Oliveira S; Breda L; Michalak M; Porto G; Rivella S; de Sousa M
    Free Radic Biol Med; 2008 Jan; 44(1):99-108. PubMed ID: 18045552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary hemochromatosis as a disease provoked by hepcidin deficiency?].
    Iwai K; Hishikawa K
    Nihon Rinsho; 2006 Sep; Suppl 3():611-5. PubMed ID: 17022620
    [No Abstract]   [Full Text] [Related]  

  • 11. Non-HFE-related hemochromatosis: the role of genetic factors.
    Castiella A; Zapata E; Otazua P; Zubiaurre L; Fernandez J
    Hepatology; 2010 Apr; 51(4):1473-4; author reply 1474. PubMed ID: 20373380
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathophysiology of hereditary hemochromatosis.
    Fleming RE; Britton RS; Waheed A; Sly WS; Bacon BR
    Semin Liver Dis; 2005 Nov; 25(4):411-9. PubMed ID: 16315135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HFE hemochromatosis: pathogenic and diagnostic approach].
    Brissot P; Le Lan C; Troadec MB; Lorho R; Ropert M; Lescoat G; Loréal O
    Transfus Clin Biol; 2005 Jun; 12(2):77-82. PubMed ID: 15925529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis.
    Merryweather-Clarke AT; Cadet E; Bomford A; Capron D; Viprakasit V; Miller A; McHugh PJ; Chapman RW; Pointon JJ; Wimhurst VL; Livesey KJ; Tanphaichitr V; Rochette J; Robson KJ
    Hum Mol Genet; 2003 Sep; 12(17):2241-7. PubMed ID: 12915468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in HAMP and HJV genes and their impact on expression of clinical hemochromatosis in a cohort of 100 Spanish patients homozygous for the C282Y mutation of HFE gene.
    Altès A; Bach V; Ruiz A; Esteve A; Felez J; Remacha AF; Sardà MP; Baiget M
    Ann Hematol; 2009 Oct; 88(10):951-5. PubMed ID: 19214511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifactorial iron man.
    Robson KJ; Drakesmith H
    Digestion; 2005; 72(1):22-4. PubMed ID: 16103672
    [No Abstract]   [Full Text] [Related]  

  • 17. Orchestration of iron homeostasis.
    Fleming RE; Bacon BR
    N Engl J Med; 2005 Apr; 352(17):1741-4. PubMed ID: 15858181
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemochromatosis: an endocrine liver disease.
    Pietrangelo A
    Hepatology; 2007 Oct; 46(4):1291-301. PubMed ID: 17886335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hereditary haemochromatosis: novel genes, novel diseases and hepcidin].
    Bergmans JP; Kemna EH; Janssen MC; Jacobs EM; Stalenhoef AF; Marx JJ; Swinkels DW
    Ned Tijdschr Geneeskd; 2007 May; 151(20):1121-7. PubMed ID: 17557668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-HFE hemochromatosis.
    Pietrangelo A
    Semin Liver Dis; 2005 Nov; 25(4):450-60. PubMed ID: 16315138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.